FTSE Russell Analytics

content.title.value
FTSE Russell Analytics

PDF, 454.44KB, 4 pages

Download
Download

Share price analysis relative to sector and index performance.

Company tear sheet

content.image.label
Company tear sheet

PDF, 61.60KB, 7 pages

Download
Download

Full issuer details available in a single file ready for sharing.

4D Pharma PLC news

Show all news
Sort by
Show 20 news
116 results (20 showing)
HeadlineSourceDateTime
ASCO 2022 MRx0518 and Bavencio Trial In Progress
RNS
27 May 2022
07:00:02
RNS 27.05.22 07:00:02
Annual Report and Notice of AGM
RNS
25 May 2022
13:51:42
RNS 25.05.22 13:51:42
ATS 2022 - MRx-4DP0004 Phase I/II Part A poster
RNS
17 May 2022
07:00:09
RNS 17.05.22 07:00:09
Final Results
RNS
01 April 2022
07:00:09
RNS 01.04.22 07:00:09
Holding(s) in Company
RNS
24 March 2022
10:50:09
RNS 24.03.22 10:50:09
MRx0518 + Keytruda - Primary endpoint met in RCC
RNS
23 March 2022
07:00:05
RNS 23.03.22 07:00:05
Holding(s) in Company
RNS
21 March 2022
10:46:41
RNS 21.03.22 10:46:41
Form F3 Registration Statement filed with SEC
RNS
09 March 2022
07:00:10
RNS 09.03.22 07:00:10
Holding(s) in Company
RNS
24 February 2022
07:21:05
RNS 24.02.22 07:21:05
Participation in Chardan Microbiome Summit
Reach
23 February 2022
07:00:05
Reach 23.02.22 07:00:05
Parkinson’s trial receives FDA IND clearance
RNS
22 February 2022
07:00:07
RNS 22.02.22 07:00:07
Restatement of Interim Results to June 30, 2021
RNS
18 February 2022
07:00:09
RNS 18.02.22 07:00:09
Additional MRx04 Phase 1/2 asthma data and event
RNS
27 January 2022
07:00:09
RNS 27.01.22 07:00:09
Holding(s) in Company
RNS
25 January 2022
17:17:07
RNS 25.01.22 17:17:07
4D pharma to host virtual KOL event
RNS
20 January 2022
07:00:09
RNS 20.01.22 07:00:09
Holding(s) in Company
RNS
06 January 2022
10:07:35
RNS 06.01.22 10:07:35
Participation in Upcoming Investor Conference
Reach
05 January 2022
07:00:08
Reach 05.01.22 07:00:08
Grant of Options
RNS
04 January 2022
07:00:13
RNS 04.01.22 07:00:13
4D pharma appoints John Doyle as CFO
RNS
04 January 2022
07:00:13
RNS 04.01.22 07:00:13
4D pharma Phase 1/2 asthma study Part A results
RNS
13 December 2021
07:00:08
RNS 13.12.21 07:00:08